R

REPLIGEN CORP

RGEN Nasdaq Healthcare · Biological Products, (No Diagnostic Substances) Waltham, MA www.repligen.com
$180.29
Mkt Cap 10.17B
—
/100 Overall
Calculating score…
Running full analysis
Ready to value this company?
Run a full DCF model with Monte Carlo simulation.
Run DCF Valuation →
📊 Key Metrics
Loading full analysis…
REVENUE TTM
$785.1M
15% CAGR
FCF TTM
$73.1M
9.3% margin
P/E RATIO
244.9x
—
P/FCF
139.3x
—
Running full 6-factor analysis…